Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Schofield

Showing results (181-190 of 337) with videos related to

Pageof 34
Sort By:
Frontiers in Genetics|April 10, 2018
A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in BloodJiyang Jiang, Anbupalam Thalamuthu, Jennifer E Ho, et al.
Neurology|June 15, 2014
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysisDavis C Ryman, Natalia Acosta-Baena, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2017
Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's diseaseBelinda M Brown, Hamid R Sohrabi, Kevin Taddei, et al.
International Journal of Molecular Sciences|April 3, 2021
Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal InvestigationPratishtha Chatterjee, Michelle Tegg, Steve Pedrini, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Science Translational Medicine|July 5, 2023
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's diseaseYun Ju Sung, Chengran Yang, Joanne Norton, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Neurology|July 26, 2013
Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseJasmeer P Chhatwal, Aaron P Schultz, Keith Johnson, et al.
Annals of Neurology|February 27, 2023
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's DiseaseKanta Horie, Yan Li, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
Pageof 34

Showing results (181-190 of 337) with videos related to

Sort By:
Pageof 34
Frontiers in Genetics|April 10, 2018
A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in BloodJiyang Jiang, Anbupalam Thalamuthu, Jennifer E Ho, et al.
Neurology|June 15, 2014
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysisDavis C Ryman, Natalia Acosta-Baena, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2017
Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's diseaseBelinda M Brown, Hamid R Sohrabi, Kevin Taddei, et al.
International Journal of Molecular Sciences|April 3, 2021
Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal InvestigationPratishtha Chatterjee, Michelle Tegg, Steve Pedrini, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Science Translational Medicine|July 5, 2023
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's diseaseYun Ju Sung, Chengran Yang, Joanne Norton, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Neurology|July 26, 2013
Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseJasmeer P Chhatwal, Aaron P Schultz, Keith Johnson, et al.
Annals of Neurology|February 27, 2023
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's DiseaseKanta Horie, Yan Li, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
Pageof 34